Sign up to save your podcasts
Or
Share Variation in Endpoints for FDA Approved Migraine Therapies
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Variation in Endpoints for FDA Approved Migraine Therapies
Dr. Jessica Ailani talks with Dr. Aaron Kesselheim and Leigh Sharpless about the endpoints used in trials supporting the US FDA approval of medications treating migraines.
Read the related article in Neurology.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
View all episodes
By American Academy of Neurology
4.7
283283 ratings
Dr. Jessica Ailani talks with Dr. Aaron Kesselheim and Leigh Sharpless about the endpoints used in trials supporting the US FDA approval of medications treating migraines.
Read the related article in Neurology.
This episode was sponsored by the ExTINGUISH Trial for NMDAR Encephalitis: Call 844-4BRAIN5 to refer patients.
More shows like Neurology® Podcast
View all
NEJM This Week
319 Listeners
JAMA Clinical Reviews
498 Listeners
Practical Neurology Podcast
51 Listeners
Mayo Clinic Talks
289 Listeners
The Curbsiders Internal Medicine Podcast
3,339 Listeners
JAMA Neurology Author Interviews
13 Listeners
Core IM | Internal Medicine Podcast
1,151 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
191 Listeners
Navigating Neuropsychology
361 Listeners
The Clinical Problem Solvers
513 Listeners
Neurology Minute
133 Listeners
Neurology Exam Prep Podcast
181 Listeners
The Curious Clinicians
372 Listeners
Continuum Audio
79 Listeners